Expert terms
Terms for healthcare professionals.
Draft v0.1 · under legal review
This document is a draft and is being reviewed by our lawyers. Highlighted items are still to be confirmed. If anything is unclear, write to ibraheem@phronem.com.
These terms are between [Phronem legal entity name: to be confirmed] (company number [company number: to be confirmed], registered office [registered office: to be confirmed]) ("Phronem", "we", "us") and the healthcare professional accepting them ("you").
1. What Phronem does
1.1 Phronem finds and schedules healthcare professionals for market research run by research agencies and consultancies (our "Clients"). The research is usually commissioned by a pharmaceutical, biotech or medical technology company (the "Sponsor").
1.2 Market research collects your professional opinions and experience. It is not promotion, advertising, a consultancy or advisory role, clinical trial recruitment, or a request for medical advice about a patient. No one will try to sell you anything or influence your prescribing.
1.3 Phronem does not conduct the interviews. The Client designs the study, asks the questions and analyses the answers.
2. Joining and projects
2.1 Accepting these terms adds you to Phronem's participant records. It does not oblige you to take part in any project, and does not guarantee that you will be invited.
2.2 For each project, we will tell you the topic in general terms, the expected length, the interview method and the payment (the "Incentive") before you agree to take part. We may not be able to tell you the Sponsor's name, to keep the research unbiased. If the Sponsor will be named during or at the end of the interview, we will tell you beforehand.
2.3 You will answer the Client's screening questions honestly. You will sign the project declaration before you are booked.
2.4 You can decline any project, and can withdraw from a project at any time, including during an interview. If you withdraw part-way through, the Incentive is paid as described in clause 5.4.
3. Your eligibility and honesty
3.1 You confirm that: (a) the identity and professional information you give us is true, complete and your own; (b) you hold the professional registration you state (for example with the GMC, NMC, GPhC, HCPC or a US state board), and it is not suspended or subject to conditions that you have not told us about; and (c) you will tell us promptly if any of this changes.
3.2 We will check your registration and identity as described in our vetting procedure. We may ask for evidence, for example a photo ID check on video, or a confirmation sent to your work email.
3.3 You must not take part under another person's name, allow anyone else to take part for you, create more than one record with us, or give answers you know to be untrue to qualify for a project. If you do, we may withhold the Incentive, remove you from our records (keeping only what we need to prevent repeat fraud), and tell the Client.
4. Conflicts, your employer and the rules that apply to you
4.1 You are responsible for making sure that taking part, and receiving the Incentive, is allowed by your employer's policies, your contract and your professional rules. For NHS staff, this includes your organisation's conflicts-of-interest policy (NHS England's "Managing Conflicts of Interest in the NHS" guidance), which may require you to declare outside work or payments.
4.2 You must not take part if doing so would breach a duty you owe to an employer, a former employer, a client, or anyone else. This includes a confidentiality agreement or a duty as a clinical trial investigator.
4.3 You must tell us before taking part if you: (a) work for, or have in the last 12 months worked for, a pharmaceutical, biotech or medical device company, or a market research company; (b) are a US federal government employee, including Veterans Affairs (VA) staff, or are otherwise restricted from receiving payments of this kind; (c) are licensed in, or practise in, a US state whose laws restrict such payments (currently screened as Vermont and West Virginia); (d) sit on a formulary, procurement, guideline or NICE committee relevant to the project topic; or (e) are an investigator on a current clinical trial relevant to the project topic. We may then decide you are not eligible for that project.
5. Incentive (payment)
5.1 The Incentive for each project is stated before you agree to take part. It reflects fair market value for your time and is never linked to what you prescribe, recommend or buy.
5.2 Phronem pays the Incentive on the Client's behalf, unless we tell you that the Client will pay you directly. We aim to pay within [number of business days: to be confirmed] after the Client confirms the interview took place, by [payment method(s): to be confirmed].
5.3 You may ask for the Incentive to be paid to a registered charity instead, where we can arrange this. A charity donation is still a payment connected with the research, and may need to be declared.
5.4 Unless the project terms say otherwise: (a) if you complete the interview, you receive the full Incentive; (b) if the Client ends the interview early for reasons not caused by you, or screens you out during the interview, you receive [the full Incentive, or a partial Incentive stated in the project invitation: to be confirmed]; (c) if you do not attend without giving at least 24 hours' notice, or withdraw before giving substantive answers, no Incentive is due; and (d) no Incentive is due if clause 3.3 applies.
5.5 Tax. You are responsible for declaring the Incentive and paying any tax due on it. Phronem does not deduct tax unless the law requires it. For US Participants, we will ask you for a Form W-9 and may issue a Form 1099 if your payments in a year reach the federal reporting threshold. We will tell you if the law requires us to share payment information with a tax authority.
5.6 US transparency reporting. Payments for market research are usually made without the Sponsor knowing who took part, and in that situation they are generally not reportable under the US Open Payments (Sunshine Act) rules. If a project is set up differently, we will tell you before you agree to take part.
6. Confidentiality
6.1 During projects you may learn confidential information, for example draft product profiles, materials, data or the Sponsor's identity. You agree: (a) to keep it confidential and not use it for any purpose other than taking part; (b) not to copy, screenshot or record the interview or the materials shown; (c) not to tell anyone (including on social media or professional networks) about the specific project, the Client or the Sponsor; and (d) to delete or return any materials you are sent, when asked.
6.2 You must not share confidential information that belongs to anyone else during an interview, including your employer, a former employer, or a clinical trial sponsor. If a question would require you to, decline to answer it.
6.3 No dealing on inside information. You must not buy or sell shares or other securities, or encourage anyone else to, using anything you learn through a project. Doing so may be a crime under the UK Market Abuse Regulation, the Criminal Justice Act 1993, or US securities law.
6.4 These duties continue after the project ends, for as long as the information remains confidential.
7. Adverse events
7.1 If, during screening or an interview, you mention an adverse event (a side effect or harm), a product complaint, or another reportable situation relating to a specific company's medicine or device, we and the Client are required to report it to the Sponsor's drug safety team. This applies even if there is no proven link to the product.
7.2 The report is made without your identity unless you agree that your contact details may be passed on so that the safety team can follow up. You will be asked at the time. Saying no does not affect your Incentive.
7.3 Please do not give patient names or other information that could identify a patient.
8. Recording and use of what you say
8.1 Interviews may be recorded, and observed live by the Client's team or the Sponsor's team. You will be told before the interview starts, and asked for your consent. If you do not consent, you can decline that project.
8.2 Your answers are used for research only. They are reported in a way that does not identify you, unless you give separate, specific consent. They will not be used to sell to you, or to identify you to the Sponsor, without that consent.
9. Your personal data
9.1 Phronem is the controller of the information in our participant records. Our privacy notice for healthcare professionals explains what we hold, where it came from and why; the lawful basis we rely on; that our team works from Pakistan as well as the UK, and how that transfer is protected; how long we keep data; who we share it with; and your rights, including to object, to access your data and to have it deleted.
9.2 For each project, we share with the Client only what it needs, such as your screening answers, your specialty and confirmation that your registration has been verified. The Client and, where named, the Sponsor may have their own privacy notices for the interview.
9.3 You can ask us to stop contacting you, or to delete your record, at any time by emailing ibraheem@phronem.com. We may keep a minimal record (for example, a "do not contact" flag, payment records required for tax, and adverse event reports) where the law or our data retention schedule requires.
10. Communications
10.1 We will contact you about projects by email and, if you agree, by text message or phone. Every email includes a way to unsubscribe. We will not send you marketing for other companies.
11. Your status
11.1 You take part as an independent individual, not as Phronem's employee, worker or agent. These terms do not create an employment relationship. You have no authority to bind Phronem.
11.2 Nothing you say in an interview is medical advice to Phronem, the Client or the Sponsor, and none of them is relying on it as such.
12. Liability
12.1 Nothing in these terms limits liability for death or personal injury caused by negligence, fraud, or any liability that cannot be limited by law.
12.2 Otherwise, Phronem's total liability to you in connection with a project is limited to the Incentive for that project, plus any amount the law does not permit to be excluded.
13. Changes and ending these terms
13.1 We may update these terms. We will tell you by email at least 14 days before changes take effect, and ask you to accept the new version before your next project.
13.2 You may end these terms at any time by emailing ibraheem@phronem.com. We may end them on notice, or immediately if you seriously breach clause 3 or 6. Clauses 5 (for Incentives already earned), 6, 7 and 9 continue after these terms end.
14. General
14.1 These terms are governed by the law of [governing law, e.g. England and Wales: to be confirmed], and its courts have jurisdiction. If you live in another part of the UK, or in the US, you may also have rights under your local law.
14.2 If any part of these terms is found invalid, the rest remains in force.
Last updated 18 November 2026. See also our privacy notices and terms.